Intrust Bank’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $212K | Buy |
2,349
+35
| +2% | +$3.21K | 0.02% | 396 |
|
|
2025
Q4 | $208K | Sell |
2,314
-1,283
| -36% | -$122K | 0.02% | 382 |
|
|
2025
Q3 | $354K | Buy |
+3,597
| New | +$356K | 0.03% | 310 |
|
|
2025
Q2 | – | Sell |
-2,533
| Closed | -$287K | – | 416 |
|
|
2025
Q1 | $287K | Sell |
2,533
-339
| -12% | -$36.3K | 0.03% | 329 |
|
|
2024
Q4 | $303K | Buy |
2,872
+687
| +31% | +$73.7K | 0.03% | 327 |
|
|
2024
Q3 | $236K | Sell |
2,185
-564
| -21% | -$61.6K | 0.02% | 363 |
|
|
2024
Q2 | $298K | Sell |
2,749
-491
| -15% | -$57.9K | 0.03% | 322 |
|
|
2024
Q1 | $428K | Sell |
3,240
-145
| -4% | -$18.1K | 0.05% | 270 |
|
|
2023
Q4 | $412K | Sell |
3,385
-403
| -11% | -$45K | 0.05% | 278 |
|
|
2023
Q3 | $425K | Buy |
3,788
+109
| +3% | +$13.8K | 0.05% | 258 |
|
|
2023
Q2 | $536K | Buy |
3,679
+64
| +2% | +$8.7K | 0.06% | 233 |
|
|
2023
Q1 | $467K | Buy |
3,615
+248
| +7% | +$31.1K | 0.06% | 248 |
|
|
2022
Q4 | $429K | Buy |
3,367
+581
| +21% | +$67.4K | 0.06% | 245 |
|
|
2022
Q3 | $291K | Buy |
2,786
+493
| +22% | +$54.1K | 0.04% | 294 |
|
|
2022
Q2 | $241K | Sell |
2,293
-628
| -21% | -$74.5K | 0.03% | 332 |
|
|
2022
Q1 | $374K | Sell |
2,921
-517
| -15% | -$62.3K | 0.05% | 287 |
|
|
2021
Q4 | $424K | Sell |
3,438
-624
| -15% | -$81.7K | 0.05% | 265 |
|
|
2021
Q3 | $578K | Sell |
4,062
-751
| -16% | -$110K | 0.08% | 212 |
|
|
2021
Q2 | $752K | Sell |
4,813
-28
| -0.6% | -$4.54K | 0.1% | 177 |
|
|
2021
Q1 | $753K | Sell |
4,841
-441
| -8% | -$68.3K | 0.11% | 170 |
|
|
2020
Q4 | $790K | Buy |
5,282
+23
| +0.4% | +$3.25K | 0.12% | 152 |
|
|
2020
Q3 | $695K | Sell |
5,259
-542
| -9% | -$70.8K | 0.12% | 149 |
|
|
2020
Q2 | $673K | Buy |
5,801
+679
| +13% | +$78.2K | 0.13% | 148 |
|
|
2020
Q1 | $503K | Sell |
5,122
-820
| -14% | -$107K | 0.14% | 159 |
|
|
2019
Q4 | $863K | Buy |
5,942
+34
| +0.6% | +$4.69K | 0.2% | 127 |
|
|
2019
Q3 | $788K | Buy |
5,908
+169
| +3% | +$21.8K | 0.2% | 131 |
|
|
2019
Q2 | $656K | Buy |
5,739
+1,547
| +37% | +$181K | 0.16% | 157 |
|
|
2019
Q1 | $520K | Buy |
4,192
+217
| +5% | +$24.7K | 0.13% | 191 |
|
|
2018
Q4 | $400K | Buy |
3,975
+334
| +9% | +$37.6K | 0.12% | 211 |
|
|
2018
Q3 | $465K | Buy |
3,641
+142
| +4% | +$16.9K | 0.12% | 205 |
|
|
2018
Q2 | $379K | Sell |
3,499
-58
| -2% | -$6.31K | 0.1% | 240 |
|
|
2018
Q1 | $377K | Sell |
3,557
-545
| -13% | -$63.3K | 0.11% | 244 |
|
|
2017
Q4 | $481K | Sell |
4,102
-157
| -4% | -$17.8K | 0.14% | 200 |
|
|
2017
Q3 | $484K | Sell |
4,259
-442
| -9% | -$51K | 0.16% | 191 |
|
|
2017
Q2 | $586K | Buy |
4,701
+370
| +9% | +$43.9K | 0.2% | 147 |
|
|
2017
Q1 | $514K | Buy |
4,331
+251
| +6% | +$28.4K | 0.18% | 164 |
|
|
2016
Q4 | $409K | Buy |
4,080
+110
| +3% | +$11.8K | 0.16% | 212 |
|
|
2016
Q3 | $501K | Buy |
3,970
+1,078
| +37% | +$133K | 0.2% | 159 |
|
|
2016
Q2 | $338K | Sell |
2,892
-678
| -19% | -$76.7K | 0.14% | 234 |
|
|
2016
Q1 | $370K | Buy |
3,570
+800
| +29% | +$77.4K | 0.13% | 190 |
|
|
2015
Q4 | $276K | Sell |
2,770
-192
| -6% | -$18.8K | 0.1% | 222 |
|
|
2015
Q3 | $270K | Buy |
2,962
+40
| +1% | +$4.01K | 0.1% | 212 |
|
|
2015
Q2 | $310K | Buy |
2,922
+202
| +7% | +$22.4K | 0.11% | 214 |
|
|
2015
Q1 | $310K | Buy |
2,720
+223
| +9% | +$25.4K | 0.11% | 209 |
|
|
2014
Q4 | $275K | Buy |
+2,497
| New | +$263K | 0.1% | 228 |
|
|
2014
Q3 | – | Sell |
-2,103
| Closed | -$212K | – | 279 |
|
|
2014
Q2 | $212K | Buy |
+2,103
| New | +$205K | 0.08% | 262 |
|
Other funds holding ZBH
VCM
VPM
Intrust Bank's ZBH Position: Q1 2026 in Review
Intrust Bank increased its Zimmer Biomet (ZBH) stake by 1.5% in Q1 2026, buying an estimated $3.21K and bringing the position to 2,349 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #396.
Intrust Bank first reported a position in ZBH in Q2 2014 and has held it in 46 quarters since. The position peaked at $863K in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Intrust Bank held 2,349 shares of Zimmer Biomet worth $212K as of Q1 2026.
- Intrust Bank bought 35 Zimmer Biomet shares in Q1 2026, an estimated $3.21K.
- Zimmer Biomet made up 0.02% of Intrust Bank's portfolio in Q1 2026, its #396 holding.
- Intrust Bank first reported a position in Zimmer Biomet in Q2 2014 and has held it in 46 quarters since.
- Intrust Bank's Zimmer Biomet position peaked at $863K in Q4 2019.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.